Global private equity and venture capital news and research

OMERS Private Equity sells lab sample testing business Maxxam for C$650m

23 Dec 2013

Opsona research labCanada’s OMERS Private Equity has agreed to sell energy, environmental, food and DNA analytics business Maxxam Analytics to Bureau Veritas for C$650m.

The company processes about 2.5 million samples and generates over 41 million results annually through Canada’s only national network of laboratories.

OMERS PE, the buyout investment arm of the OMERS pension plan, has more than $6bn of investments under management.

In October Mid Europa Partners made its second bolt-on deal in the Central European laboratory space in the space of a week with Diagnostyka’s acquisition of Polish pathology company Olympus Consilio.

This transaction marked a further step in Mid Europa’s strategy to consolidate the market, it said. Earlier this week, the firm announced the acquisition of Euromedic Labs in the Czech Republic.

Copyright © 2013 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016